Itus corp stock

ITUS Corp - ITUS Stock Chart Technical Analysis for 01-09 ... Jan 09, 2018 · ITUS Corp - ITUS Stock Chart Technical Analysis for 01-09-18 Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/ Free Guide - The 5 Tools

SNNLive spoke with David Hottman, CEO of Orestone Mining Corp. SNNLive caught up with Amit Kumar, CEO of ITUS Corporation (NASDAQ: ITUS) at the  Why Buy Penny Stocks? Mobile (MEDL) Stock Keeps On Climbing · 3 Stocks To Keep An Eye On: BSTA, PENC, GRMS · Penny Stocks To Watch | ITUS Corp. Sysco Return on Investment ROI, current and historic results by quarter and year, rankings and averages from Dec 28 2019 to Dec 29 2018 - CSIMarket. Compare up to five stocks using any one of over 50 fundamental indicators. Start Comparing China, $1.360B, 18.06. Viad Corp (VVI), United States, $1.252B, 34.61 ITUS (ITUS), United States, $0.071B, 0.00. Cinedigm Corp (CIDM)  Real-time discussion about Falcon Gold Corp (FG. @Thrive Its great $FG can support the stock, they also might need to boost $IMT PP to get that site drilled 

ITUS Corp (NASDAQ:ITUS) Up Big On Patent ... - Oracle Dispatch

ITUS Corporation (ITUS). YHD - YHD Delayed Price. Currency in USD. Add to watchlist. As of June 28 6:07PM EDT. Market open. Summary · Chart · Historical  28 Sep 2018 ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX. ITUS Logo (PRNewsfoto/ITUS  28 Sep 2018 ITUS Corporation (ITUS +1.2%) announced that the Company will officially change its name to Anixa Biosciences, Inc. effective at the start of  Sign up for email Updates. Be The First to Receive Breaking News. Sign Up Now. Logo Itus Stock Data. Mar 06, 2020 • 4:00 PM EST View Investors Relations. ITUS Corporation quote is equal to 4.640 USD at 2020-04-01. Based on our forecasts, a long-term increase is expected, the "ITUS" stock price prognosis for 2023-  Yet investors have purchased millions of dollars of its stock, hoping to cash in on what they see as promising technology. By Carol Steinberg. Sept. 20, 1992. A  ITUS (OTCQB:ITUS) will reduce the number of ITUS's issued and outstanding common stock from approximately 219 million shares to approximately 8.8 million  

ITUS: Get the latest ITUS stock price and detailed information including ITUS news, BRIEF-Itus Corp - Co Entered Into An At Market Issuance Sales Agreement 

ITUS Corp Archives - Stock News Union Sep 22, 2017 · ITUS Corp (NASDAQ:ITUS) ITUS Corp (NASDAQ:ITUS) traded higher after providing an update on its new cancer detection system, Cchek, and a new CAR-T initiative for ovarian cancer.The stock was up by 6.21% to cap an impressive week that saw the stock rally by more than 40%. One month ITUS stock price chart ITUS - Itus Corp Stock Profile - Barchart.com Company profile for Itus Corp (ITUS) including business summary, key statistics, ratios, sector. A stock's Profile page contains general information about the stock, such as Ticker Symbol, Exchange traded on, Company Contact Address/Phone, CEO/President, and Company Description. It also includes links to the Industry, Sector, and Index in

28 Sep 2018 ITUS Corporation (ITUS +1.2%) announced that the Company will officially change its name to Anixa Biosciences, Inc. effective at the start of 

ITUS Corporation - The New York Times A Stock Thrives Without a Product. A SMALL research and development company in Huntington Station that keeps its operations under tight wraps may be on the verge of a market breakthrough or it may ITUS Corporation - Home | Facebook Mar 21, 2016 · ITUS Corporation. 90 likes. ITUS Corporation's primary focus is Cchek™, a platform for non-invasive blood tests for the early detection of solid tumor based cancers.

ITUS Corp. (NASDAQ:ITUS) has 2 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,615 shares. Largest shareholders include Denver Investment Advisors Llc, and BlackRock Fund Advisors.

ITUS: NA - Interactive Chart Chart. Get the latest Interactive Chart for NA from Zacks Investment Research It also includes an industry comparison table to see how your stock compares to its

ITUS CORP : Stock Price | MarketScreener Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the … ITUS CORP : Stock Market News and Information ... More sector news : Biotechnology & Medical Research - NEC: Upcoming sector events. 02/25/20: EXELIXIS, INC.: FY 2019 Earnings Release Itus Corp announces a reverse stock split and the launch ... ITUS (OTCQB:ITUS) will reduce the number of ITUS's issued and outstanding common stock from approximately 219 million shares to approximately 8.8 million shares in a 1 for 25 reverse stock split effective at 9:00 am EST on June 26, 2015. ITUS Corp (ITUS) Stock: A Pleasant Surprise Adds ...